NewsRoom Articles - Page 115 of 116 - PsychedelicNewsWire (PNW)

WednesdayJun 21, 2017 9:46 am

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives…

ThursdayJun 15, 2017 8:00 am

Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments

PsychedelicNewsWire Editorial Coverage: Alzheimer’s disease is a devastating brain disorder that now affects about 5.3 million Americans, accounting for one in nine people over the age of 65, according to the Alzheimer’s Association. One in three seniors die with the disease or another form of dementia, and, while treatments to slow or stop the disease’s progression have been lacking, several pharmaceutical companies are working to change that. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), which has products that are backed by data of cannabis-based combination therapies to treat Alzheimer’s, pain, seizures and a host of neurological and oncological issues,…

TuesdayJun 06, 2017 3:05 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy

With about 50 million people affected worldwide, drug-resistant epilepsy, or refractory epilepsy, is a very serious condition for which a medical solution has not yet been found, but the therapeutic benefits of phytocannabinoid-based therapies for seizures have been coming under increased scrutiny lately. There is mounting evidence that cannabinoid extracts, and in particular cannabidiol (CBD), can have a positive impact on epilepsy patients and alleviate seizures, as indicated by recent research. Companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are at the forefront of discovering cannabinoid-based epilepsy treatments for humans and animals alike, by developing innovative formulations that…

WednesdayMay 24, 2017 9:00 am

Evolution of Marijuana Industry Creates Wealth of Opportunity for Companies with Foresight and Action

PsychedelicNewsWire Editorial Coverage: The marijuana industry continues to evolve at a breakneck pace in the United States, and an increasing number of businesses are finding their niche in this rampant market as it burns toward nationwide legalization. In the wake of this evolution, various new types of businesses are emerging to provide the consumer and commercial markets with products and services such as branding and packaging, smoke lounges, cultivation operations, grow equipment, pain management, payment solutions and numerous others. SinglePoint, Inc. (SING) (SING Profile), Medical Marijuana, Inc. (MJNA), Kush Bottles, Inc. (KSHB), Scott’s Miracle-Gro Co. (SMG) and Canopy Growth Corp.…

TuesdayMay 23, 2017 1:08 pm

ChineseInvestors.com (CIIX) Growing Rapidly in a Rapidly Growing Market

Savvy investors study multiple factors to identify potential stock winners. Stock screeners scan thousands of companies for insights and data to discern uncommon opportunities. The criteria utilized in a stock screening system is obviously influenced by an individual’s investment proclivities such as high yield, value, growth or price momentum, however, most stock screening systems are typically hybrids with blended criteria reflecting individual preferences and incorporating more than one investment style. P/E ratios, near zero beta, increased dividends, revenue growth and market growth are all employed to sift through over 100,000 public companies around the world and the nearly 6,000 U.S.…

WednesdayMay 17, 2017 9:00 am

Cannabis-Based Therapies with Potential to Dull the Pain of Opioid Abuse

PsychedelicNewsWire Editorial Coverage: America is in an opioid epidemic. On an average day, 91 Americans will die from an opioid-related overdose. That’s according to the CDC, which also reports that the number of prescription opioids sold in the U.S. has nearly quadrupled since 1999 despite no overall change in the amount of pain reported. The result is more than half a million deaths by opioid overdose from 2000 to 2015. These sobering figures reveal the desperate need for opioid substitutes, and cannabis-based therapies for pain treatment are emerging as viable alternatives. The potential rewards are significant for companies that can…

WednesdayMay 10, 2017 9:00 am

Marijuana Stocks Drive Corporate Value by Delivering Automation, Technology and Diverse Application

PsychedelicNewsWire Editorial Coverage: The marijuana market is ripe with investment opportunities, and the leaders of the pack are those who demonstrate the vision and ability to increase corporate value. Be it through revolutionary technology, health applications, packaging and accessories, cultivation tools or other means, companies like SinglePoint, Inc. (SING) (SING Profile), Kush Bottles, Inc. (KSHB), Insys Therapeutics, Inc. (INSY), Solis Tek, Inc. (SLTK) and Medical Marijuana, Inc. (MJNA) are capturing their share of a burgeoning market and presenting investors with unique and exciting opportunities to climb aboard. In North America, the cannabis market was valued at approximately $7.2 billion in…

TuesdayMay 09, 2017 3:23 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by…

MondayMay 08, 2017 12:55 pm

India Globalization Capital, Inc. (NYSE: IGC) Positioned to Lead in Phytocannabinoid Pharmaceuticals

A study recently highlighted by the American Epilepsy Society (AES) at its 70th annual meeting focused on the potential of cannabidiol (CBD), a derivative of the cannabis plant, as a promising treatment for reducing both the frequency and severity of seizures in children with drug resistant epilepsies (http://nnw.fm/u3xAh). According to the study, patients who received CBD treatment exhibited over 45 percent mean reduction in seizures, and researchers were outspoken in support of further research. Cannabidiol is the most abundant non-psychoactive cannabinoid found in the cannabis plant. Both anecdotal evidence and pre-clinical research have suggested that CBD may have a broad…

FridayMay 05, 2017 2:37 pm

India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History

Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies. Cannabis’ history doesn’t begin in the 1960s. Scientists have dated burned cannabis seeds found in Siberia to 3,000 B.C., and mummified psychoactive marijuana has been found in tombs of individuals buried around 2,500 B.C. Fast forward a few thousand years and add laws, regulations, and cultural stigma, and behold one of the most disputed substances. In the 1850s, recreational cannabis was considered fashionable in the U.S., and it was…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050